首页 › 基金 › Palo Alto Investors LP › ANL

Palo Alto Investors LP 对 ANL 的持仓历史

ADLAI NORTYE GROUP LTD · 医疗保健

Palo Alto Investors LP 在 Q3 2026 的 13F 申报中披露持有 ANL(ADLAI NORTYE GROUP LTD)149,490 股,市值约 US$2.4M,约占其申报组合的 0.36%,在其申报持仓中市值排名第 36 位。 Palo Alto Investors LP 于 Q3 2026 首次申报该持仓。

最新持仓 (Q3 2026)149.49K 股
申报持仓市值$2.39M
组合权重0.36%
首次申报Q3 2026
最近变动新进
更新于2026-11-17

最后更新: 2026-11-17 · 来源: SEC EDGAR Form 13F-HR

Palo Alto Investors LP 对 ANL 的持仓演变

Palo Alto Investors LP 于 Q3 2026 首次披露 ANL 持仓:149,490 股(约 US$2.4M)。

逐季持仓明细

季度股数金额变化
Q3 2026 149.49K $2.39M 新进

关于 ANL 与 13F 数据

ANL(ADLAI NORTYE GROUP LTD)属于医疗保健行业。我们追踪的基金中还有 53 只申报持有 ANL,申报仓位最大的包括:Cormorant Asset Management, LP (US$63.7M), Venrock Adviser, LLC (US$51.4M), MPM BioImpact LLC (US$31.3M)。 根据美国 SEC 规定,管理资产超过 1 亿美元的机构投资者须在每季度结束后 45 天内提交 13F 表,披露其美股多头持仓。该数据不包含空头、大部分期权及海外持仓,因此应将其视为季度快照而非实时仓位。

其它持有 ANL 的基金

查看 ANL 的全部基金持有人 →

常见问题

How long has Palo Alto Investors LP held ANL?

Palo Alto Investors LP has disclosed ANL holdings in 1 of the last 1 reported quarters, going back to Q3 2026.

What is Palo Alto Investors LP's current position in ANL?

As of Q3 2026, Palo Alto Investors LP holds 149.49K shares of ANL (ADLAI NORTYE GROUP LTD), valued at $2.39M, representing 0.36% of its reported portfolio and ranking #36.

Has Palo Alto Investors LP been buying or selling ANL?

In the latest 13F filing (Q3 2026), Palo Alto Investors LP newly opened its position in ANL.

Which other funds hold ANL?

Other major institutional holders of ANL include Cormorant Asset Management, LP, Venrock Adviser, LLC, MPM BioImpact LLC, among 53 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.